Leigh Hsu
Corporate Officer/Principal bei CARSGEN THERAPEUTICS HOLDINGS LIMITED
Aktive Positionen von Leigh Hsu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Corporate Officer/Principal | 01.06.2017 | - |
Karriereverlauf von Leigh Hsu
Ehemalige bekannte Positionen von Leigh Hsu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 19.02.2013 | - |
Ausbildung von Leigh Hsu
| University of California San Diego | Doctorate Degree |
| University of California, Irvine | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
